Optellum, a 2016 University of Oxford spinout, will deploy its AI lung-cancer diagnostic with the NHS to improve early detection and reduce invasive procedures.
Longevity News
Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service to use...
Source: FierceBiotech - Medtech • Published: 20 Feb 2026, 21:00
Continue exploring
Related longevity signals
PR NewswireAnbogen Therapeutics and The University of Tokyo Enter Collaborative Research Agreement to Evaluate ABT-301 Across Multiple Tumor Types, Targeting Accelerated Human Clinical Indication ExpansionComparative oncology collaboration examining a selective cancer therapy in naturally occurring animal tumors to guide which human indications and combinations to pursue.Longevity TechnologyWhat if aging research has been studying the wrong sex?A Perspective argues that female biology and reproductive history may hold overlooked insights into aging and resilience, proposing a new evolutionary framework.Fight Aging!Bacterial Lipoic Acid Protein Ligase A Improves Mammalian Mitochondrial Function and HealthThis article previews research on using a bacterial enzyme to boost mitochondrial protein modification and overall cellular energy, framed as a potential metabolic-enhancing therapy. It invites readers curious about cross-species gene therapy approaches aimed at improving healthspan and age-related function.Fight Aging!Mistranslation Mutations in Flies Surprisingly Extend LifeReports on how specific RNA-to-protein mistranslation mutations in fruit flies produce a surprising, sex-specific lifespan increase and reproductive resilience.